Kiva Genetics Inc. (Now DNA Sciences Inc.)
This article was originally published in Start Up
Executive Summary
While gene sequencing and gene expression technologies have become relatively industrialized, genetic analysis is a time-consuming, labor intensive, and rate-limiting step in drug discovery. Kiva Genetics hopes to remove this bottleneck with a high-throughput system that miniaturizes and automates genotyping.